Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval ·

FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms

View source ↗

Summary

FDA approves Orzeyful (oveporexton) tablets as the first drug to treat the full range of narcolepsy type 1 symptoms in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orzeyful (oveporexton)

Snippet

The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.